Smac Mimetic LCL161

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Drug Information

Target Indication

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Clinical Trial

Last updated: 8/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

NVS

Novartis AG

Related Pipeline

Chronic Plaque Type Psoriasis

Pathological Myopia

Renal Interstitial Fibrosis

Prostatic Neoplasms

Melanoma

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts